SEC Form 4 · accession 0001209191-15-075846
MERRIMACK PHARMACEUTICALS INC · MACK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward J. Stewart
Officer — Head of Commercial
Period of report
Oct 16, 2015
Accepted (ET)
Oct 16, 2015 · 7:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001274792
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 16, 2015 | M | 1,000 | $1.81 | A | 22,385 | D | |
| Common Stock | Oct 16, 2015 | S | 1,000 | $10.00 | D | 21,385 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $1.81 | Oct 16, 2015 | M | 1,000 | D | — | Sep 22, 2018 | Common Stock | 1,000 | 23,000 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- F2This option is fully vested.